Effects of liraglutide in hypothalamic arcuate nucleus of obese mice

The neuroprotective effects of liraglutide (200 μg/kg, twice daily, subcutaneous administration) in the hypothalamic arcuate nucleus (ARC) of diet‐induced obese mice were investigated.

[1]  C. Hölscher,et al.  Restoration of Cerebral and Systemic Microvascular Architecture in APP/PS1 Transgenic Mice Following Treatment with Liraglutide™ , 2015, Microcirculation.

[2]  S. Briyal,et al.  Neuroprotective and anti-apoptotic effects of liraglutide in the rat brain following focal cerebral ischemia , 2014, Neuroscience.

[3]  J. Hecksher-Sørensen,et al.  The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss. , 2014, The Journal of clinical investigation.

[4]  T. Ando,et al.  Liraglutide as a potentially useful agent for regulating appetite in diabetic patients with hypothalamic hyperphagia and obesity. , 2014, Internal medicine.

[5]  L. Miller-Fleming,et al.  Microglia and inflammation: conspiracy, controversy or control? , 2014, Cellular and Molecular Life Sciences.

[6]  Nu-Chu Liang,et al.  Long term exendin-4 treatment reduces food intake and body weight and alters expression of brain homeostatic and reward markers. , 2014, Endocrinology.

[7]  C. Hölscher.  Central effects of GLP-1: new opportunities for treatments of neurodegenerative diseases. , 2014, The Journal of endocrinology.

[8]  R. Seeley,et al.  Hormones and diet, but not body weight, control hypothalamic microglial activity , 2014, Glia.

[9]  J. Jansson,et al.  Glucagon-like peptide 1 receptor induced suppression of food intake, and body weight is mediated by central IL-1 and IL-6 , 2013, Proceedings of the National Academy of Sciences.

[10]  T. Rabelink,et al.  Glucagon-like peptide-1 receptor agonist treatment reduces beta cell mass in normoglycaemic mice , 2013, Diabetologia.

[11]  Elizabeth K. Unger,et al.  Modulation of AgRP-neuronal function by SOCS3 as an initiating event in diet-induced hypothalamic leptin resistance , 2013, Proceedings of the National Academy of Sciences.

[12]  C. Hölscher,et al.  Liraglutide protects against amyloid-β protein-induced impairment of spatial learning and memory in rats , 2013, Neurobiology of Aging.

[13]  M. Deyoung,et al.  GLP-1 receptor activated insulin secretion from pancreatic β-cells: mechanism and glucose dependence , 2012, Diabetes, obesity & metabolism.

[14]  C. Mandarim-de-Lacerda,et al.  Maternal High-Fat Diet Programs for Metabolic Disturbances in Offspring despite Leptin Sensitivity , 2012, Neuroendocrinology.

[15]  C. Hölscher,et al.  Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis , 2012, BMC Neuroscience.

[16]  M. R. Hayes,et al.  GLP-1 neurons in the nucleus of the solitary tract project directly to the ventral tegmental area and nucleus accumbens to control for food intake. , 2012, Endocrinology.

[17]  Joshua A. Smith,et al.  Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases , 2012, Brain Research Bulletin.

[18]  M. Dietrich,et al.  Obesity is associated with hypothalamic injury in rodents and humans. , 2012, The Journal of clinical investigation.

[19]  H. Grill,et al.  Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4. , 2011, Endocrinology.

[20]  Christian Hölscher,et al.  The Diabetes Drug Liraglutide Prevents Degenerative Processes in a Mouse Model of Alzheimer's Disease , 2011, The Journal of Neuroscience.

[21]  C. Hölscher,et al.  Novel GLP‐1 mimetics developed to treat type 2 diabetes promote progenitor cell proliferation in the brain , 2011, Journal of neuroscience research.

[22]  H. Grill,et al.  Intracellular signals mediating the food intake-suppressive effects of hindbrain glucagon-like peptide-1 receptor activation. , 2011, Cell metabolism.

[23]  M. Cowley,et al.  Diet-induced obesity causes ghrelin resistance in arcuate NPY/AgRP neurons. , 2010, Endocrinology.

[24]  L. B. Knudsen.  Liraglutide: the therapeutic promise from animal models , 2010, International journal of clinical practice. Supplement.

[25]  S. Griffen,et al.  Chronic Administration of the Glucagon-Like Peptide-1 Analog, Liraglutide, Delays the Onset of Diabetes and Lowers Triglycerides in UCD-T2DM Rats , 2010, Diabetes.

[26]  Jens C. Brüning,et al.  Integrative neurobiology of energy homeostasis-neurocircuits, signals and mediators , 2010, Frontiers in Neuroendocrinology.

[27]  J. Friedman.  Obesity: Causes and control of excess body fat , 2009, Nature.

[28]  J. Carvalheira,et al.  High-Fat Diet Induces Apoptosis of Hypothalamic Neurons , 2009, PloS one.

[29]  J. Carvalheira,et al.  Saturated Fatty Acids Produce an Inflammatory Response Predominantly through the Activation of TLR4 Signaling in Hypothalamus: Implications for the Pathogenesis of Obesity , 2009, The Journal of Neuroscience.

[30]  H. Neumann,et al.  Debris clearance by microglia: an essential link between degeneration and regeneration , 2008, Brain : a journal of neurology.

[31]  Kathryn Moynihan Ramsey,et al.  High-fat diet disrupts behavioral and molecular circadian rhythms in mice. , 2007, Cell metabolism.

[32]  M. W. Schwartz,et al.  Central nervous system control of food intake and body weight , 2006, Nature.

[33]  M. Morris,et al.  Adaptive responses in hypothalamic neuropeptide Y in the face of prolonged high‐fat feeding in the rat , 2003, Journal of neurochemistry.

[34]  J. Hwa,et al.  Characterization of diet-induced obese rats that develop persistent obesity after 6 months of high-fat followed by 1 month of low-fat diet , 2002, Brain Research.

[35]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[36]  C. Mantzoros,et al.  Differential expression of hypothalamic neuropeptides in the early phase of diet-induced obesity in mice. , 2000, American journal of physiology. Endocrinology and metabolism.

[37]  S. Woods,et al.  Central nervous system control of food intake , 2000, Nature.

[38]  P. G. Reeves,et al.  AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. , 1993, The Journal of nutrition.

[39]  H. Gundersen,et al.  Notes on the estimation of the numerical density of arbitrary profiles: the edge effect , 1977 .